Dipongkor saha - Search Results

Year	Number of Results
2011	4
2012	3
2014	3
2015	3
2016	4
2017	2
2018	3
2019	2
2020	4
2021	5
2022	5
2023	4
2024	6
2025	5
2026	4

1

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.

Bommareddy PK, Wakimoto H, Martuza RL, Kaufman HL, Rabkin SD, Saha D. Bommareddy PK, et al. Among authors: saha d. J Immunother Cancer. 2024 Apr 9;12(4):e008880. doi: 10.1136/jitc-2024-008880. J Immunother Cancer. 2024. PMID: 38599661 Free PMC article.

2

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade.

Saha D, Martuza RL, Rabkin SD. Saha D, et al. Oncoscience. 2017 Sep 20;4(7-8):67-69. doi: 10.18632/oncoscience.359. eCollection 2017 Jul. Oncoscience. 2017. PMID: 28966936 Free PMC article. No abstract available.

3

Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.

Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, Rabkin SD, Saha D. Wang H, et al. Among authors: saha d. Hum Gene Ther. 2023 Sep;34(17-18):878-895. doi: 10.1089/hum.2023.099. Hum Gene Ther. 2023. PMID: 37578106 Free PMC article. Review.

4

Emerging biologics for the treatment of pulmonary arterial hypertension.

Hye T, Hossain MR, Saha D, Foyez T, Ahsan F. Hye T, et al. Among authors: saha d. J Drug Target. 2023 Jun;31(5):1-15. doi: 10.1080/1061186X.2023.2199351. Epub 2023 Apr 26. J Drug Target. 2023. PMID: 37026714 Free PMC article. Review.

5

Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors.

Hudson M, Newman RH, Rorie CJ, Holloman BL, Kaufman HL, Rabkin SD, Graves J Jr, Saha D. Hudson M, et al. Among authors: saha d. Cancer Gene Ther. 2025 Nov;32(11):1166-1176. doi: 10.1038/s41417-025-00960-2. Epub 2025 Sep 16. Cancer Gene Ther. 2025. PMID: 40957993 Free PMC article. Review.

6

Antibody-drug conjugates: an evolving approach for melanoma treatment.

Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB. Anderson TS, et al. Among authors: saha d. Melanoma Res. 2021 Feb 1;31(1):1-17. doi: 10.1097/CMR.0000000000000702. Melanoma Res. 2021. PMID: 33165241 Review.

7

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.

Saha D, Rabkin SD, Martuza RL. Saha D, et al. J Immunother Cancer. 2020 May;8(1):e000345. doi: 10.1136/jitc-2019-000345. J Immunother Cancer. 2020. PMID: 32457126 Free PMC article.

8

An evolving perspective on novel modified release drug delivery systems for inhalational therapy.

Hye T, Moinuddin SM, Sarkar T, Nguyen T, Saha D, Ahsan F. Hye T, et al. Among authors: saha d. Expert Opin Drug Deliv. 2023 Mar;20(3):335-348. doi: 10.1080/17425247.2023.2175814. Epub 2023 Feb 16. Expert Opin Drug Deliv. 2023. PMID: 36720629 Free PMC article. Review.

9

Pathogenetic Features and Current Management of Glioblastoma.

Nguyen HM, Guz-Montgomery K, Lowe DB, Saha D. Nguyen HM, et al. Among authors: saha d. Cancers (Basel). 2021 Feb 18;13(4):856. doi: 10.3390/cancers13040856. Cancers (Basel). 2021. PMID: 33670551 Free PMC article. Review.

10

Optimal timing of PD-1 blockade in combination with oncolytic virus therapy.

Nguyen HM, Bommareddy PK, Silk AW, Saha D. Nguyen HM, et al. Among authors: saha d. Semin Cancer Biol. 2022 Nov;86(Pt 3):971-980. doi: 10.1016/j.semcancer.2021.05.019. Epub 2021 May 24. Semin Cancer Biol. 2022. PMID: 34033895 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year